Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.43 +0.01 (+0.04%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,794,507
Open 24.33
Bid (Size) 24.42 (800)
Ask (Size) 24.44 (3,800)
Prev. Close 24.42
Today's Range 24.11 - 24.63
52wk Range 20.91 - 27.69
Shares Outstanding 5,606,688,356
Dividend Yield 7.04%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Market Reels from Volatility and Mixed Signals: A Deep Dive into Investor Unease
The past week, from November 1st to November 8th, 2025, has witnessed a significant shift in global market sentiment, moving decisively towards a "risk-off" stance. Investors are grappling with... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
2 No-Brainer Dividend Stocks to Buy With $100 in November
There's no need to break the bank to get your hands on excellent dividend payers. 
Via The Motley Fool
Topics Economy World Trade

Performance

YTD
-8.2%
-8.2%
1 Month
-3.2%
-3.2%
3 Month
-0.6%
-0.6%
6 Month
+5.8%
+5.8%
1 Year
-8.6%
-8.6%

More News

Read More
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.
Via The Motley Fool
Topics Government
Global Virtual Summit Puts the Spotlight on Sickle Cell Caregivers
Via 24-7 Press Release
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Via Benzinga
Deal Dispatch: From A Founder Comeback To Billion-Dollar Bids, This Week In M&A And Bankruptcy
Via Benzinga
Why Novo Nordisk Stock Is Sinking This Week
Via The Motley Fool
Topics Government World Trade
The Stock Market Is Signaling a Recession. Here's How to Prepare Your Portfolio.
Via MarketMinute
Topics Bonds Economy Stocks
Friday's session: most active stock in the S&P500 index
Via Chartmill
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
Via Investor's Business Daily
Topics Government
Tech Sell-Off Rocks Wall Street: Nasdaq, S&P 500, and Dow Sink Amidst Brutal Week for Stocks
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
Sangamo (SGMO) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Famed Investor Michael Burry Bets Against Nvidia and Palantir to the Tune of $1.1 billion. Is He Right?
Via The Motley Fool
Topics Artificial Intelligence
US Stocks Tumble Amid AI Valuation Fears and Mounting Job Worries
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx
Via Benzinga
Topics Government
Stay informed about the most active stocks in the S&P500 index on Thursday's session.
Via Chartmill
3 Value Stocks That Fall Short
Via StockStory
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
Via Benzinga
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further
Via Stocktwits
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
Via MarketMinute
Topics Intellectual Property
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
Via Investor's Business Daily
Market Momentum Stalls: Valuations Under Scrutiny as Bullish Run Faces Headwinds
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
Viatris’s (NASDAQ:VTRS) Q3 Sales Top Estimates
Via StockStory
Why Pfizer's 7%-Yielding Dividend Just Became Safer -- and More Tempting
Via The Motley Fool
Topics Earnings Intellectual Property

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.43
When was Pfizer last traded?
The last trade of Pfizer was at 11/07/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 136.97B
How many shares of Pfizer are outstanding?
Pfizer has 137B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.